Recent Quotes (30 days)

You have no recent quotes
chg | %

Healthcare News

Showing stories 1 - 10 of about 70   
Johnson & Johnson is trying to sell its diabetes care business to Chinese ...
Johnson & Johnson, the world's largest health care company, is seeking to sell off its diabetes care businesses, including LifeScan, Animas, and Calibra.
Stats on Johnson & Johnson
Analysts have gotten increasingly optimistic about Johnson & Johnson earnings. They've generally kept their short-term projections unchanged, but 1% boosts to both full-year 2017 and 2018 predictions reflect the bullishness that many shareholders feel ...
Is Johnson & Johnson a Buy?
Johnson & Johnson's (NYSE:JNJ) mission is to "help people everywhere live longer, healthier, happier lives." For decades, the healthcare titan has done just that, while also delivering tremendous returns to shareholders along the way.
Coming Out Of Shadows? MetLife, Inc. (MET), Johnson & Johnson (JNJ)  Market Movers
Johnson & Johnson Issues Statement on ZYTIGA� Inter Partes Reviews
NEW BRUNSWICK, N.J., Jan. 17, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) issued the following statement regarding today's Inter Partes Reviews regarding ZYTIGA� (abiraterone acetate):. "We are disappointed in and strongly disagree with the U.S ...
France fines Johnson & Johnson about $30 million over painkiller patch
French authorities fined Johnson & Johnson $29.62 million after it found the company had deliberately slowed market access to generic copies of Durogesic.
Johnson & Johnson fined 25 mln euros by French competition watchdog  Reuters
Intel, Johnson & Johnson, UPS: 'Fast Money' Picks For January 18
A summary of each day's top rating changes from sell-side analysts on the street. Fintech Focus. Your weekly roundup of hot topics in the exciting world of fintech.
UnitedHealth Group Inc Stock Pops on Earnings Beat
UnitedHealth Group Inc (NYSE:UNH) stock was up today following the release of its earnings report for the fourth quarter of 2017. UnitedHealth Group Inc Stock Pops on Earnings Beat.
UnitedHealth Group Stock Climbs on Glowing Report  U.S. News & World Report
Rising Health Care Costs and UnitedHealth Group Inc (NYSE: UNH)  Stock Traders Daily
US court invalidates Johnson & Johnson cancer drug patent, hitting UK's BTG
NEW YORK (Reuters) - A U.S. administrative court invalidated a Johnson & Johnson (JNJ.N) patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions and hitting shares in its British partner BTG Plc (BTG.
No More Tears: Johnson & Johnson Is Still in an Uptrend and Keeping Me Humble
Johnson & Johnson (JNJ) has continued to rally despite my analysis that doubted the strength of this stock. Hey, sometimes I get it wrong but the upside has been I have had a very nice exchange in recent weeks with one subscriber who has made money on ...
Why Johnson & Johnson (JNJ) Is Being Added to Investors Watchlist?  StockNewsGazette
Marathon Asset Management LLP Has $245.39 Million Stake in Johnson & ...  Week Herald
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2018
NEW BRUNSWICK, N.J., Jan. 2, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2018 of $0.84 per share on the company's common stock.
Johnson & Johnson (JNJ) Closes 0.6% Down on the Day for January 01  Equities.com
Digging Up the Facts on Johnson & Johnson (JNJ)  StockNewsJournal